Exclusive

Publication

Byline

Location

US Patent Issued to Chugai Seiyaku on Aug. 11 for "Antibody constant region variant" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,738, issued on Aug. 11, was assigned to Chugai Seiyaku K.K. (Tokyo). "Antibody constant region variant" was invented by Tomoyuki Igawa (Shi... Read More


US Patent Issued to VANDERBILT UNIVERSITY on Aug. 11 for "Human antibodies to rift valley fever virus" (Tennessee Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,739, issued on Aug. 11, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.). "Human antibodies to rift valley fever virus" was invente... Read More


US Patent Issued to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Aug. 11 for "GKN1 (gastrokine 1) specific antibody, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,740, issued on Aug. 11, was assigned to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seoul, South Korea). "GK... Read More


US Patent Issued to AVEO Pharmaceuticals on Aug. 11 for "Treatment of congestive heart failure and other cardiac dysfunction using a GDF15 modulator" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,741, issued on Aug. 11, was assigned to AVEO Pharmaceuticals Inc. (Boston). "Treatment of congestive heart failure and other cardiac dysfun... Read More


US Patent Issued on Aug. 11 for "Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereof" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,742, issued on Aug. 11. "Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereof" was invented by Hq Han (West... Read More


US Patent Issued to Akeso Biopharma on Aug. 11 for "Anti-CD47 monoclonal antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,743, issued on Aug. 11, was assigned to Akeso Biopharma Inc. (Zhongshan, China). "Anti-CD47 monoclonal antibody and use thereof" was invent... Read More


US Patent Issued to National Research Council of Canada on Aug. 11 for "Anti-CD22 single domain antibodies and therapeutic constructs" (Canadian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,744, issued on Aug. 11, was assigned to National Research Council of Canada (Ottawa). "Anti-CD22 single domain antibodies and therapeutic c... Read More


US Patent Issued to Adaptate Biotherapeutics on Aug. 11 for "Anti-TCR delta variable 1 antibodies" (British Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,746, issued on Aug. 11, was assigned to Adaptate Biotherapeutics Ltd. (London). "Anti-TCR delta variable 1 antibodies" was invented by Mihr... Read More


US Patent Issued to PRECIGEN on Aug. 11 for "Fusion constructs and methods of using thereof" (Maryland Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,747, issued on Aug. 11, was assigned to PRECIGEN INC. (Germantown, Md.). "Fusion constructs and methods of using thereof" was invented by H... Read More


US Patent Issued to Xencor on Aug. 11 for "Anti-CD28 compositions" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,748, issued on Aug. 11, was assigned to Xencor Inc. (Pasadena, Calif.). "Anti-CD28 compositions" was invented by John R. Desjarlais (Pasade... Read More